ISO TS 22456-2021 PDF

ISO TS 22456-2021 PDF

Sterilization of healthcare products-Microbiological methods-Guidance on conducting bioburden determinations and tests of sterility for biologics and tissue-based products

$71.50 $143.00 -50%
Product Code: ISO TS 22456
Stock In Stock
Edition: 1ST
Published: 03/2021
Number of Pages: 20
File Size: 1 file, 1 Byte

Available Options

Product Description

Sterilization of healthcare products — Microbiological methods — Guidance on conducting bioburden determinations and tests of sterility for biologics and tissue-based products

Introduction: The sources and types of some microorganisms, as well as the test methods used to evaluate biologics and tissue-based products, can be unique relative to other health care products, such as plastic and metal medical devices. This document provides guidance to address issues that are applicable to the microbiological testing of biologics and tissue-based products, where this testing constitutes bioburden testing or a test of sterility performed in relation to product sterilization. Except where otherwise indicated in this document, the requirements in ISO 11737-1:2018 and ISO 11737-2:2019 apply. © ISO 2021 – All rights reserved

Scope: 1.1 Inclusions 1.1.1 This document provides guidance for bioburden testing and tests of sterility for biologics and tissue-based products, where this testing is in relation to product sterilization. NOTE This document is intended to be used in conjunction with ISO 11737-1 and ISO 11737-2. 1.1.2 Guidance in this document can be applicable to biologics and tissue-based products that are not sterile but are microbiologically controlled. 1.2 Exclusions 1.2.1 This document does not include guidance for validation requirements for testing, eliminating and/or inactivating viruses and prions or sterilization of tissue-based products. NOTE Guidance on inactivating viruses and prions can be found in ISO 22442-3. 1.2.2 This document does not include guidance for containment or biosafety issues for biologics and tissue-based products. 1.2.3 This document does not include guidance for testing biologics and tissue-based products for specific infectious agents as listed in relevant national or international guidance (e.g. viruses/protozoa/ parasites, intracellular microorganisms or mycoplasma screening). 1.2.4 This document does not include guidance for the acceptance criteria for biologics and tissue- based products during procurement or tissue to be processed and/or released for use. 1.2.5 This document does not include guidance for the testing associated with procurement and screening of biologics and tissue-based products.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 22456-2021 PDF

ISO TS 22456-2021 PDF

$71.50 $143.00